Status:

COMPLETED

Pulse Oximetry- Evaluating Resp Rate- PCBA-1

Lead Sponsor:

Medtronic - MITG

Conditions:

Healthy Subjects

Eligibility:

All Genders

18-50 years

Brief Summary

To assess performance of resp rate parameter in a monitoring system PCBA-1

Eligibility Criteria

Inclusion

  • Male or female subjects ages 18 or older.
  • Subject is willing and able to provide written consent.

Exclusion

  • Subject has severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors.
  • Subjects with abnormalities that may prevent proper application of the device.
  • Subjects with significant Arrhythmia, as determined by subject self-report during screening and I/E criteria assessment at study start. (Three events of irregularities in radial pulse within thirty seconds).
  • Women who are pregnant or lactating.

Key Trial Info

Start Date :

October 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2012

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT01791582

Start Date

October 1 2012

End Date

October 1 2012

Last Update

December 6 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Covidien

Boulder, Colorado, United States, 80301